Rani Therapeutics Holdings, Inc.
RANINasdaqCIK 1856725HealthcareFiscal year ends Dec 31
Reports and events: 104 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1316:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349245 |
| 2026-08-1316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349197 |
| 2026-08-0408:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-331594 |
| 2026-06-3018:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001856725-26-000003 |
| 2026-05-2918:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-245636 |
| 2026-05-2817:47 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001699737-26-000014 |
| 2026-05-2720:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-239977 |
| 2026-05-1516:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-226703 |
| 2026-05-1516:08 ET | 8-K | 2.02 Results of operations; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-226691 |
| 2026-04-1616:46 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001140361-26-015157 |
| 2026-03-2616:43 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-126417 |
| 2026-03-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126240 |
| 2026-01-0217:27 ET | 8-K | 1.02 Termination of a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-001098 |
| 2025-11-0616:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269774 |
| 2025-11-0616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269722 |
| 2025-10-3019:50 ET | SCHEDULE 13D | Ownership report, active investor | 0001699737-25-000014 |
| 2025-10-2721:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001873082-25-000003 |
| 2025-10-2706:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-25-250614 |
| 2025-10-2219:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-101616 |
| 2025-10-1707:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-241963 |
| 2025-08-0716:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105045 |
| 2025-08-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104998 |
| 2025-07-1614:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-159793 |
| 2025-06-2616:06 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-090384 |
| 2025-05-2916:09 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-078949 |
| 2025-05-2008:59 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-122872 |
| 2025-05-1316:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070382 |
| 2025-05-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070344 |
| 2025-05-0617:15 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-064624 |
| 2025-04-3008:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-060586 |
| 2025-04-1608:02 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001140361-25-014078 |
| 2025-04-0916:21 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-052527 |
| 2025-03-3116:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047740 |
| 2025-03-3116:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047701 |
| 2024-11-1408:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126763 |
| 2024-11-1408:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126753 |
| 2024-10-1716:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-109546 |
| 2024-10-1606:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-237838 |
| 2024-09-1116:10 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-24-105509 |
| 2024-08-0616:09 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091793 |
| 2024-08-0616:04 ET | 8-K | 9.01 Financial statements and exhibits | 0000950170-24-091744 |
| 2024-07-2306:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-182549 |
| 2024-07-1217:19 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-24-083284 |
| 2024-06-2407:16 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-166293 |
| 2024-05-3016:03 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-066552 |
| 2024-05-0616:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053548 |
| 2024-05-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053527 |
| 2024-04-1708:00 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001140361-24-020199 |
| 2024-03-2016:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-034163 |
| 2024-03-2016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034153 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.